Medical Optics News

RSS

FDA Grants Cutera enlighten Laser Platform 510(k) Clearance for Treatment of Benign Pigmented Lesions

Cutera, Inc., a leading provider of laser, light and other energy-based aesthetic systems for practitioners worldwide, announced that its enlighten laser platform received U.S. Food and Drug Administration 510(k) clearance for the treatment of benign pigmented lesions. enlighten is the first and only dual wavelength (532 nm/1064 nm) and dual pulse duration picosecond laser system cleared for sale in the United States.

14 Aug 2014

Brien Holden Vision Institute Employs Phasefocus High-Precision Lens Profiler for Developing Contact Lenses

Phase Focus Ltd (Phasefocus), the company that is revolutionising microscopy and imaging with the Phasefocus Virtual Lens®, reports on how the Brien Holden Vision Institute is applying the Phasefocus high-precision Lens Profiler to assist in the development of new contact lenses.

13 Aug 2014

MRI Guides High-Intensity Ultrasound Waves to Destroy Benign Bone Tumours

A patient at The Hospital for Sick Children (SickKids) is the first child in North America to have undergone a specialized procedure that uses ultrasound and magnetic resonance imaging (MRI) to destroy a tumour in his leg without piercing the skin.

7 Aug 2014

New Hand-Held, Lasers and Sound Waves-Based Device to Treat Melanoma

A new hand-held device that uses lasers and sound waves may change the way doctors treat and diagnose melanoma, according to a team of researchers from Washington University in St. Louis. The instrument, described in a paper published today in The Optical Society's (OSA) journal Optics Letters, is the first that can be used directly on a patient and accurately measure how deep a melanoma tumor extends into the skin, providing valuable information for treatment, diagnosis or prognosis.

7 Aug 2014

New Optics and the Brain Topical Meeting Announced by the OSA

The Optical Society (OSA) today announced the formation of a new topical meeting, OSA Optics and the Brain. The meeting will bring together physicists, engineers, neuroscientists and clinicians whose research combines optics and photonics with exploration of the brain.

From Optical Society Of America 6 Aug 2014

Pen-Sized 3-in-1 Spectroscopy System May Help Early Detection of Cancer

Researchers in the Cockrell School of Engineering at The University of Texas at Austin have designed an optical device that may reduce the number of unnecessary biopsies by offering a fast, comprehensive, noninvasive and lower-cost solution to detect melanoma and other skin cancer lesions.

6 Aug 2014

SPIE Introduces New Journal on Neurophotonics

The advanced optical methods and applications for imaging and manipulation of the brain that are driving a revolution in the neurosciences were the inspiration behind Neurophotonics, a new peer-reviewed journal published by SPIE, the international society for optics and photonics.

30 Jul 2014

Wearable Prototype Pupillometer May Enable Early Diagnosis of Diabetic Autonomic Neuropathy

A group of researchers in Taiwan has developed a new optical technology that may be able to detect an early complication of diabetes sooner, when it is more easily treated. If the device proves safe and effective in clinical trials, it may pave the way for the early detection and more effective treatment of this complication, called diabetic autonomic neuropathy, which is common among people with both Type 1 and Type 2 diabetes.

From Optical Society Of America 29 Jul 2014

FDA Grants 510(k) Clearance to Spectranetics’ Peripheral Laser Atherectomy Products

The Spectranetics Corporation today announced receipt of U.S. Food and Drug Administration (FDA) 510(k) clearance of their peripheral atherectomy products, Turbo-Tandem® and Turbo Elite®, for the treatment of in-stent restenosis (ISR). The clearance prompts a new standard of care in ISR treatment with improved clinical outcomes.

25 Jul 2014

Laser Clinique Offers FDA Approved Ultherapy Décolletage Treatment at San Diego Facility

Laser Clinique announces it is now offering the new ultherapy décolletage treatment out of its facilities in San Diego, following recent approval from the Food and Drug Administration.

21 Jul 2014